- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 96.17M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $2.09M |
| Capex | Q1 2025 · Mar 31, 2024 | $270K |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.4M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $2.4M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $271.96M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $273.88M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $540.23M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $514.83M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $75.49M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $49.64M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $224.35M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $203.78M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $464.63M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $420.15M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $801.61M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $756.39M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 99.75M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $54.84M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $12.49M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$186K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.09M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $11.96M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $12.37M |
| Revenue | Q1 2025 · Mar 31, 2024 | $24.32M |